A-Pak Laboratories Paediatric Analgesic Paracetamol Interactions
There are 156 drugs known to interact with A-Pak Laboratories Paediatric Analgesic Paracetamol (acetaminophen), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 8 are major, 112 are moderate, and 36 are minor.
- View all 156 medications that may interact with A-Pak Laboratories Paediatric Analgesic Paracetamol
- View A-Pak Laboratories Paediatric Analgesic Paracetamol alcohol/food interactions (1)
- View A-Pak Laboratories Paediatric Analgesic Paracetamol disease interactions (3)
Most frequently checked interactions
View interaction reports for A-Pak Laboratories Paediatric Analgesic Paracetamol (acetaminophen) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- amlodipine
- amoxicillin
- Anexsia (acetaminophen / hydrocodone)
- aspirin
- atenolol
- atropine
- Avastin (bevacizumab)
- Campral (acamprosate)
- cannabis
- Durabac Forte (acetaminophen / caffeine / magnesium salicylate / phenyltoloxamine)
- Epzicom (abacavir / lamivudine)
- Intal Inhaler (cromolyn)
A-Pak Laboratories Paediatric Analgesic Paracetamol alcohol/food interactions
There is 1 alcohol/food interaction with A-Pak Laboratories Paediatric Analgesic Paracetamol (acetaminophen).
A-Pak Laboratories Paediatric Analgesic Paracetamol disease interactions
There are 3 disease interactions with A-Pak Laboratories Paediatric Analgesic Paracetamol (acetaminophen) which include:
More about A-Pak Laboratories Paediatric Analgesic Paracetamol (acetaminophen)
- Compare alternatives
- Latest FDA alerts (16)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous analgesics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.